Skip to main content
Toggle navigation
Menu
Overall search
Search ClinicalINFO
In affiliation with
HIV.gov
Search
Close
Main navigation
Home
About
Guidelines
Drug Database
Glossary
News
Resources
Contact Us
English
Toggle Dropdown
English
Español (Spanish)
Home
Search Results
Overall search
Search ClinicalINFO
Search Results
3281 – 3300
of
3979
Pneumocystis Pneumonia
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/pneumocystis
Bictegravir
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/bictegravir
Financial Disclosure
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/financial-disclosure
Hepatic Events
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/hepatic-events
When to Initiate Antiretroviral Treatment in Children with HIV Infection
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/when-initiate-therapy-antiretroviral-naive-children
Initial Postnatal Management of the Neonate Exposed to HIV
https://clinicalinfo.hiv.gov/guidelines/perinatal/management-infants-initial-postnatal-neonate-exposed-hiv
Appendix A: General Terms
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/appendix-general-terms
What's New in the Guidelines
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/whats-new
Histoplasmosis
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/histoplasmosis
Maraviroc
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/maraviroc
Zalcitabine (Hivid, ddC)
https://clinicalinfo.hiv.gov/guidelines/perinatal/archived-drugs-zalcitabine-hivid
Appendix D: Supplemental Information
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/appendix-d-supplemental-information
Appendix A: List of Abbreviations
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/appendix-list
Adherence to Antiretroviral Therapy in Children and Adolescents With HIV
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/adherence-antiretroviral-therapy-children-and-adolescents-living-hiv
Guidance for Non-HIV-Specialized Providers Caring for Persons with HIV Who Have Been Displaced by Disasters (such as a Hurricane)
https://clinicalinfo.hiv.gov/guidelines/guidelines-caring-persons-hiv-disaster-areas/guidance-non-hiv-specialized-providers
Cytomegalovirus
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-pediatric-opportunistic-infections/cytomegalovirus
Abacavir
https://clinicalinfo.hiv.gov/guidelines/pediatric-arv/abacavir
Appendix A: Key to Acronyms
https://clinicalinfo.hiv.gov/guidelines/perinatal/appendix-a-acronyms
Elvitegravir (EVG)
https://clinicalinfo.hiv.gov/guidelines/perinatal/safety-toxicity-arv-agents-integrase-inhibitors-elvitegravir
Appendix B: Herpes (HSV/VZV)
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-opportunistic-infections/appendix-b-7
Pagination
First page
«
Previous page
‹
…
Page
161
Page
162
Page
163
Page
164
Current page
165
Page
166
Page
167
Page
168
Page
169
…
Next page
›
Last page
»